학술논문

Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study
Document Type
Article
Source
In: RMD Open. (RMD Open, 26 March 2024, 10(1))
Subject
Language
English
ISSN
20565933